Avantor stock triggered by recent price slide

Avantor (AVTR) has attracted closer attention after its share price fell about 10% over the past month and roughly 18% in the past 3 months, against a backdrop of continued profitability challenges.

The recent slide fits into a longer stretch of weaker sentiment, with the share price down 33% year to date and the 1 year total shareholder return falling 43%, suggesting momentum has been fading despite ongoing revenue and income growth.

If Avantor's volatility has you rethinking your watchlist, this could be a good moment to broaden your research and check out 29 healthcare AI stocks

With Avantor trading at a discount to some intrinsic estimates, yet carrying a recent net loss and weak multi year shareholder returns, should you see the current price as a reset opportunity or a sign that markets are already pricing in future growth?

Most Popular Narrative: 23% Undervalued

Avantor's most followed narrative estimates a fair value of $9.92 per share versus the last close at $7.64, putting a clear spotlight on what assumptions sit underneath that gap.

The continued acceleration of biologics, gene therapies, and personalized medicine creates an increasing need for specialized and single-use solutions, an area where Avantor is investing in market-leading platforms and expanding innovation, positioning the company to benefit from secular end-market growth and product mix shift toward higher-margin segments, supporting margin and earnings growth.

Want to see what is doing the heavy lifting in this valuation? The narrative leans on a careful mix of steady revenue, rising margins, and a lower future earnings multiple than many peers.

Result: Fair Value of $9.92 (UNDERVALUED)

However, this narrative still faces real pressure from intense pricing competition and concerns that elevated leverage could restrict Avantor's room to respond if conditions remain challenging.

Next Steps

With sentiment clearly split between concern and optimism, this is a good moment to look through the figures yourself and decide where you stand, then weigh up the 3 key rewards and 1 important warning sign

Looking for more investment ideas?

If Avantor's recent moves have you reassessing your portfolio, do not stop here. Use focused stock lists to spot fresh ideas and avoid potential missed opportunities.

• Target resilient cash generators with the solid balance sheet and fundamentals stocks screener (46 results), which highlights companies pairing financial strength with underlying fundamentals.
• Spot potential value opportunities early through the 54 high quality undervalued stocks, which surfaces stocks that trade below certain fundamental estimates.
• Hunt for underfollowed opportunities via the screener containing 21 high quality undiscovered gems, a list of companies that combine quality metrics with lower market attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.